KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 156 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q2 2015. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $587,000 | +18.6% | 7,790 | -21.0% | 0.11% | +25.0% |
| Q1 2015 | $495,000 | +44.7% | 9,861 | 0.0% | 0.09% | +60.0% |
| Q4 2014 | $342,000 | +5.9% | 9,861 | 0.0% | 0.06% | +34.1% |
| Q3 2014 | $323,000 | -6.1% | 9,861 | +9.9% | 0.04% | +13.9% |
| Q2 2014 | $344,000 | -3.6% | 8,971 | 0.0% | 0.04% | -12.2% |
| Q1 2014 | $357,000 | -5.3% | 8,971 | -11.2% | 0.04% | -14.6% |
| Q4 2013 | $377,000 | -18.0% | 10,097 | 0.0% | 0.05% | -35.1% |
| Q3 2013 | $460,000 | +68.5% | 10,097 | 0.0% | 0.07% | +37.0% |
| Q2 2013 | $273,000 | – | 10,097 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AlpInvest Partners B.V. | 48,087 | $1,668,000 | 4.13% |
| Versant Venture Management, LLC | 70,376 | $2,440,640,000 | 2.33% |
| Palo Alto Investors LP | 1,121,884 | $38,907,000 | 2.28% |
| Aureus Asset Management, LLC | 124,087 | $4,303,000 | 1.05% |
| PFM Health Sciences, LP | 1,085,315 | $37,639,000 | 0.88% |
| HARBOURVEST PARTNERS LLC | 39,318 | $1,364,000 | 0.72% |
| REGENTATLANTIC CAPITAL LLC | 176,454 | $6,119,425,000 | 0.52% |
| Partner Investment Management, L.P. | 24,456 | $848,000 | 0.35% |
| Old West Investment Management, LLC | 15,162 | $525,000 | 0.32% |
| Polar Capital LLP | 405,544 | $14,063,000 | 0.27% |